Angelo Willems

Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma.

Karin Vanderkerken, Evy De Leenheer, C M Shipman et al. · PubMed · 2003 · 189 citations

Medicine, Oncology, Pharmacology +17

Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression.

Kewal Asosingh, Hendrik De Raeve, Mark De Ridder et al. · PubMed · 2005 · 99 citations

Medicine, Hematology, Oncology +16

Inhibition of p38α Mitogen-Activated Protein Kinase Prevents the Development of Osteolytic Bone Disease, Reduces Tumor Burden, and Increases Survival in Murine Models of Multiple Myeloma

Karin Vanderkerken, Satya Medicherla, Les Coulton et al. · Cancer Research · 2007 · 43 citations · Full text

Medicine, Oncology, Pharmacology +15

The 5T2MM Murine Model of Multiple Myeloma: Maintenance and Analysis

Karin Vanderkerken, Kewal Asosingh, Angelo Willems et al. · Humana Press eBooks · 2005 · 31 citations

Medicine, Cancer Biology, Oncology +16

Delayed in vivo disease progression is associated with high proportions of CD45+ myeloma cells in the 5T2MM murine model.

Kewal Asosingh, Angelo Willems, Ivan Van Riet et al. · PubMed · 2003 · 13 citations

Medicine, Immunology, Pathology +13